UBS Group Issues Positive Forecast for Exelon (NASDAQ:EXC) Stock Price
UBS Group upped their target price on shares of Exelon from $45.00 to $47.00 and gave the stock a “neutral” rating in a report on Friday.
Source link
UBS Group upped their target price on shares of Exelon from $45.00 to $47.00 and gave the stock a “neutral” rating in a report on Friday.
Source link
If you believe the product behaved incorrectly (for example: did not open/close a trade, set wrong SL/TP, failed to copy parameters, etc.), the fastest way to help you is to get facts: logs + a specific trade/signal example. “Doesn’t work” without details is not actionable. 1) Before you post a comment Try to reproduce the issue…
Indian equities posted broad-based gains in May 2025, led by a stellar 22% surge in defence stocks and strong double-digit returns in microcap indices, as investors rotated into risk-on segments amid improving domestic sentiment and supportive global cues. The Nifty Microcap 250 jumped 12.10% in May, marking the strongest performance among major indices, while the…
US government debt is up more than 9,000% since the value of the dollar was severed from gold in August of 1971. This has permitted massive deficit spending by Washington and a national debt approaching $40 trillion [Click to open in a new window] ‘I have a stone in my shoe. You can remove it.’…
Thought I'd start a post on this little explorer. Up 56% today. Recent news about a JV deal and exploration in Saudi Arabia. Still early days though. Source link
Insurance aggregator PB Fintech on Thursday reported a consolidated net profit growth of 185% in Q4FY25 at Rs 171 crore versus Rs 60 crore reported in the year ago period. The company’s revenue from operations in the March-ended quarter stood at Rs 1,508 crore, which was up 38% over Rs 1,090 crore in the corresponding…
Lance Jepsen Lance Jepsen is the senior personal finance writer for Guerilla Stock Trading who has spent more than 25 years covering the stock market and economics. In addition, Lance has worked as a private stock analyst for a number of high worth individuals. Source link